Splenic Artery Embolization for Refractory Ascites Following Hepatectomy for Hepatocellular Carcinoma
- 11 February 2026
- journal article
- research article
- Published by Springer Nature in Indian Journal of Surgical Oncology
- Vol. 17 (4) , 728-733
Abstract
Surgery (Resection/Liver transplant) remains the only curative modality for the treatment of hepatocellular carcinoma (HCC). Post hepatectomy liver failure is the Achilles heel of liver surgery. Management of refractory ascites (RA), following a major resection especially in cirrhotic patients presents a formidable clinical challenge as it is often resistant to conventional treatment modalities. A 72-year gentleman diagnosed with hepatocellular carcinoma in the right lobe of liver with future liver remanent of 45% underwent a right hepatectomy. Postoperatively, despite conservative management with diuretics and albumin he had significantly high drain output. On the 10th day, he underwent proximal splenic artery embolization following which there was a progressive reduction in ascites and drain output. He was discharged in stable condition on the 15th day. Histopathology confirmed moderately differentiated HCC with adjacent steatohepatitis. The patient wass stable and disease free at the 3-month follow-up. Splenic artery embolization offers a safe and minimally invasive technique for management of RA post hepatectomy. Further studies are needed to conclusively establish the safety and utility of this procedure.Keywords
This publication has 20 references indexed in Scilit:
- BCLC strategy for prognosis prediction and treatment recommendation: The 2022 updateJournal of Hepatology, 2021
- Proximal Splenic Artery Embolization to Treat Refractory Ascites in a Patient With CirrhosisHepatology, 2021
- Post-operative Ascites After Hepatectomy—Not More Than What Meets the EyesJournal of Gastrointestinal Surgery, 2021
- Post hepatectomy liver failure (PHLF) – Recent advances in prevention and clinical managementEuropean Journal of Surgical Oncology, 2021
- Transjugular Intrahepatic Portosystemic Shunt: Indications, Contraindications, and Patient Work-UpSeminars in Interventional Radiology, 2014
- Development of Hong Kong Liver Cancer Staging System With Treatment Stratification for Patients With Hepatocellular CarcinomaGastroenterology, 2014
- Complications arising from splenic artery embolization: a review of an 11-year experienceThe American Journal of Surgery, 2013
- Posthepatectomy liver failure: A definition and grading by the International Study Group of Liver Surgery (ISGLS)Surgery, 2011
- Risk Factors and Management of Ascites After Liver Resection to Treat Hepatocellular CarcinomaArchives of Surgery, 2009
- High-Risk Surgical Patients: Why We Should Pre-Optimize2003